RCD ESCS May 27, 2016 Protocol Title: Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS) Protocol Number: 15-EI-0052 Date of This Submission/Version: May 27, 2016/ v5.0 Principal Investigator (PI) Bldg. 10, Wadih Zein, MD NEI/NIH 301-496-8118
[email protected] Rm. 10D45 Accountable Investigator Bldg. 10, Wadih Zein, MD NEI/NIH 301-496-8118
[email protected] Rm. 10D45 Associate Investigators (AI) Bldg. 10, Catherine Cukras, MD, PhD NEI/NIH 301-435-5061
[email protected] Rm. 10C438 Bldg. 10, Brett Jeffrey, PhD NEI/NIH 301-402-2391
[email protected] Rm. 10C442 Bldg. 10, Emily Chew, MD NEI/NIH 301-496-6583
[email protected] Rm. 3-2531 Bldg. 10, Amy Turriff, ScM NEI/NIH 301-402-4175
[email protected] Rm. 11C432B Bldg. 10, Henry Wiley, MD NEI/NIH 301-451-4260
[email protected] Rm. 10D45 Bldg. 6, Wai T. Wong, MD, PhD NEINIH 301-496-7566
[email protected] Rm. 217 Bldg. 10, Brian Brooks, MD, PhD NEI/NIH 301-451-2238
[email protected] Room 10B16 Bldg. 35, Kapil Bharti, PhD NEI/NIH 301-496-9661
[email protected] Rm. 2A-102 Bldg. 6, Anand Swaroop, PhD NEI/NIH 301-435-5754
[email protected] Rm. 338 Bldg. 10, Arvydas Maminishkis, PhD NEI/NIH 301-435-4902
[email protected] Rm. 10B04 Bldg. 31, Sheldon Miller, PhD NEI/NIH 301-496-3180
[email protected] Rm.